Department of Neurosurgery, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan.
School of Nursing, College of Nursing, Taipei Medical University, Taipei, Taiwan.
Biomed J. 2021 Dec;44(6 Suppl 1):S48-S53. doi: 10.1016/j.bj.2020.06.004. Epub 2020 Jun 12.
Awake craniotomy is an effective method by which to reduce postoperative neurologic deficit in newly-diagnosed glioma patients. However, the level of functional preservation in patients undergoing resection of recurrent glioma remains unknown. Therefore, this study aimed to evaluate functional outcomes in patients with recurrent glioma undergoing awake craniotomy as compared with conservative general anesthesia craniotomy for tumor resection.
We retrospectively reviewed 225 patients who had recurrent gliomas from May 2013 to January 2016 in our institution. New-onset neurological deficits were evaluated on postoperative day 7 (early) and at 3 months (late). General performance was assessed both preoperatively and at 3 months postoperatively.
The early neurological deficit rate was 3.8% in the awake craniotomy group and 21.6% in the general anesthesia group (p. 0.032), while the late neurological deficit rates were 3.8% and 11.5%, respectively (p. 0.231). Moreover, 46.1% of patients in the awake craniotomy group and 12.6% in the general anesthesia group demonstrated an improvement in the Karnofsky performance status (KPS) score (p < 0.001).
Awake craniotomy is an effective and safe method by which to perform recurrent glioma surgery. The neurological outcomes and general performance after awake craniotomy in recurrent glioma patients were better than those in patients undergoing general anesthesia craniotomy.
清醒开颅术是降低新诊断的胶质母细胞瘤患者术后神经功能缺损的有效方法。然而,对于复发性胶质瘤患者切除术后的功能保留程度尚不清楚。因此,本研究旨在评估与保守的全身麻醉开颅术相比,复发性胶质瘤患者接受清醒开颅术的功能结果。
我们回顾性分析了 2013 年 5 月至 2016 年 1 月期间在我院就诊的 225 例复发性脑胶质瘤患者。术后第 7 天(早期)和第 3 个月(晚期)评估新发神经功能缺损。在术前和术后 3 个月评估一般表现。
清醒开颅组的早期神经功能缺损发生率为 3.8%,全身麻醉组为 21.6%(p.0.032),晚期神经功能缺损发生率分别为 3.8%和 11.5%(p.0.231)。此外,清醒开颅组 46.1%的患者和全身麻醉组 12.6%的患者卡氏行为状态(KPS)评分提高(p<0.001)。
清醒开颅术是治疗复发性脑胶质瘤的一种有效且安全的方法。与全身麻醉开颅术相比,复发性脑胶质瘤患者接受清醒开颅术的神经功能结局和一般表现更好。